A
correction
to this article has been published: Spiller et al., J. Exp. Med. 205 (9) 2177
Published online July 21, 2008
doi:10.1084/jem.20071990
The Journal of Experimental Medicine, Vol. 205, No. 8, 1747-1754
The Rockefeller University Press, 0022-1007 $30.00
© 2008 Spiller et al.
TLR4-induced IFN-
production increases TLR2 sensitivity and drives Gram-negative sepsis in mice
Stephan Spiller1,
Greg Elson2,
Ruth Ferstl1,
Stefan Dreher1,
Thomas Mueller1,
Marina Freudenberg3,
Bruno Daubeuf2,
Hermann Wagner1, and
Carsten J. Kirschning1
1 Institute of Medical Microbiology, Immunology, and Hygiene, Technische Universität München, 81675 Munich, Germany
2 Novimmune S.A., 1228 Plan-Les-Ouates, Switzerland
3 Max Planck Institute of Immunobiology, 79108 Freiburg, Germany
CORRESPONDENCE Carsten J. Kirschning:carsten.kirschning{at}lrz.tum.de
Gram-negative bacterial infection is a major cause of sepsis and septic shock. An important inducer of inflammation underlying both syndromes is the cellular recognition of bacterial products through pattern recognition receptors (PRRs), including Toll-like receptors (TLRs). We identified a novel antagonistic mAb (named 1A6) that recognizes the extracellular portion of the TLR4–MD-2 complex. If applied to mice before infection with clinical isolates of Salmonella enterica or Escherichia coli and subsequent antibiotic therapy, 1A6 prevented otherwise fatal shock, whereas application of 1A6 after infection was ineffective. In contrast, coapplication of 1A6 and an anti-TLR2 mAb up to 4 h after infection with Gram-negative bacteria, in combination with the start of antibiotic therapy (mimicking clinical conditions), provided robust protection. Consistent with our findings in mice, dual blockade of TLR2 and TLR4 inhibited TNF-
release from human peripheral blood mononuclear cells upon Gram-negative bacterial infection/antibiotic therapy. Both murine splenocytes and human PBMCs released IFN-
in a TLR4-dependent manner, leading to enhanced surface TLR2 expression and sensitivity for TLR2 ligands. Our results implicate TLR2 as an important, TLR4-driven sensor of Gram-negative bacterial infection and provide a rationale for blockade of both TLRs, in addition to antibiotic therapy for the treatment of Gram-negative bacterial infection.
S. Spiller and G. Elson contributed equally to this paper.
© 2008 Spiller et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Raby, A.-C., Le Bouder, E., Colmont, C., Davies, J., Richards, P., Coles, B., George, C. H., Jones, S. A., Brennan, P., Topley, N., Labeta, M. O.
(2009). Soluble TLR2 Reduces Inflammation without Compromising Bacterial Clearance by Disrupting TLR2 Triggering. J. Immunol.
183: 506-517
[Abstract]
[Full Text]
-
Carsillo, T., Carsillo, M., Traylor, Z., Rajala-Schultz, P., Popovich, P., Niewiesk, S., Oglesbee, M.
(2009). Major Histocompatibility Complex Haplotype Determines hsp70-Dependent Protection against Measles Virus Neurovirulence. J. Virol.
83: 5544-5555
[Abstract]
[Full Text]
-
Ungaro, R., Fukata, M., Hsu, D., Hernandez, Y., Breglio, K., Chen, A., Xu, R., Sotolongo, J., Espana, C., Zaias, J., Elson, G., Mayer, L., Kosco-Vilbois, M., Abreu, M. T.
(2009). A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am. J. Physiol. Gastrointest. Liver Physiol.
296: G1167-G1179
[Abstract]
[Full Text]
-
O'Neill, L. A. J., Bryant, C. E., Doyle, S. L.
(2009). Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer. Pharmacol. Rev.
61: 177-197
[Abstract]
[Full Text]
-
Fowler, R. A., Adhikari, N. K. J., Scales, D. C., Lee, W. L., Rubenfeld, G. D.
(2009). Update in Critical Care 2008. Am. J. Respir. Crit. Care Med.
179: 743-758
[Full Text]
-
Jung, I. D., Lee, M.-G., Chang, J. H., Lee, J. S., Jeong, Y.-I., Lee, C.-M., Park, W. S., Han, J., Seo, S.-K., Lee, S. Y., Park, Y.-M.
(2009). Blockade of Indoleamine 2,3-Dioxygenase Protects Mice against Lipopolysaccharide-Induced Endotoxin Shock. J. Immunol.
182: 3146-3154
[Abstract]
[Full Text]
-
Roger, T., Froidevaux, C., Le Roy, D., Reymond, M. K., Chanson, A.-L., Mauri, D., Burns, K., Riederer, B. M., Akira, S., Calandra, T.
(2009). Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc. Natl. Acad. Sci. USA
106: 2348-2352
[Abstract]
[Full Text]